| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 29 | 0 | 444 | 948 | 5.065 | 2.345 | 1.136 | 849 | 422 |
| Total Income - EUR | - | 29 | 0 | 444 | 948 | 5.065 | 2.345 | 1.136 | 849 | 422 |
| Total Expenses - EUR | - | 309 | 291 | 0 | 765 | 23 | 934 | 3.853 | 968 | 260 |
| Gross Profit/Loss - EUR | - | -280 | -291 | 444 | 183 | 5.042 | 1.411 | -2.718 | -119 | 163 |
| Net Profit/Loss - EUR | - | -281 | -291 | 431 | 155 | 4.917 | 1.347 | -2.750 | -119 | 137 |
| Employees | - | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pro Bionaturadaro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 2.714 | 2.477 | 2.224 | 1.969 |
| Current Assets | - | 170 | 4 | 448 | 610 | 5.578 | 3.664 | 1.049 | 1.139 | 1.555 |
| Inventories | - | 124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 121 | 223 | 222 | 221 |
| Cash | - | 45 | 4 | 448 | 610 | 5.578 | 3.543 | 826 | 917 | 1.334 |
| Shareholders Funds | - | -237 | -524 | -83 | 73 | 4.989 | 6.225 | 3.494 | 3.364 | 3.481 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 406 | 528 | 531 | 536 | 590 | 154 | 32 | 0 | 42 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Pro Bionaturadaro S.r.l.